← Back to All Filings

Labcorp Holdings EVP & CIO Reports Routine RSU Vest and Tax Withholding

Low SignificanceNovember 3, 2026 at 10:36:43 AM EST

LABCORP HOLDINGS INC.

$LH4CIK: 0000920148

Subscribe to track LH

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

📋 SEC Form 4 Filing: LABCORP HOLDINGS INC. ($LH)

Insider: Oyegunwa Akinbolade (EVP, CIO & CTO) Transaction Date: November 2, 2026 Type: Tax Withholding (Code F) Shares Transacted: 118 shares disposed at $355.59 ($41,959.62) RSU Vesting: 370 shares acquired via RSU conversion (Code M) on November 1, 2026 Post-Transaction Holdings: 5,316.253 Common Shares Significance: Low (Routine vesting & mandatory tax withholding)

Comprehensive Analysis

Executive Summary

On November 3, 2026, LABCORP HOLDINGS INC. ($LH) filed a Form 4 disclosing transactions by Akinbolade Oyegunwa, Executive Vice President, Chief Information Officer & Chief Technology Officer. The transactions reflect the routine vesting of Restricted Stock Units (RSUs) and an accompanying share withholding to satisfy tax obligations.

Transaction Breakdown

  1. RSU Vesting (Code M):

    • Date: November 1, 2026
    • Shares Acquired: 370 shares of Common Stock upon conversion of RSUs at $0.00.
    • Derivative Table: 370 RSUs were settled from a grant that vests in three equal annual installments beginning November 1, 2025. Following the settlement, 2,570 RSUs remain held.
  2. Tax Withholding (Code F):

    • Date: November 2, 2026
    • Shares Disposed: 118 shares of Common Stock
    • Price Per Share: $355.59
    • Total Value Withheld: $41,959.62

Ownership Status

Following these transactions, Akinbolade Oyegunwa directly owns 5,316.253 shares of Labcorp Holdings Inc. Common Stock, in addition to 2,570 unvested RSUs.

Market and Trading Impact

  • Trading Significance: Low
  • Rationale: These transactions were non-discretionary, administrative actions related to equity compensation vesting and tax liabilities. There were no open-market purchases or sales.
Topics:#Labcorp#LH#SEC#Form4#InsiderTrading#Healthcare

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.